Drug discovery is the process of determining an active compound lead compound with advantageous biological activity
A wide range of advanced technologies—including high throughput screening genomics, proteomics, and computational methods provides tens of thousands of biological targets that disease-fighting compounds can effect. Any effective drug must be validated for safety/toxicity and mode of action.
Pharmaceutical companies require accurate and efficient target identification and one of the main bottlenecks of drug discovery and development is compound validation. Laboratory automation is a key technology for any company undertaking these studies offering rapid compound screening, improved data reliability and analysis.
PAA is a leading supplier of drug discovery platforms which have been used by pharmaceutical, biotech companies and research institutes and universities over the last 25 years, with over 600 systems installed worldwide. We offer a wide range of solutions for discovery automation with a range of both small workstations and large workcells with a complete portfolio of robotic plate manipulators, sample preparation and analysis instruments, control software and enclosures to ensure rapid and safe active compound discovery.